Brokerage firm Motilal Oswal believes that PFC's risk-reward is attractive considering decent visibility on loan growth, ...

Brokerage firm CLSA has a "high conviction outperform" rating on the stock with a target price of ₹360 per share, indicating ...

A new anti-malarial compound has been designed to target disease-causing parasites responsible for up to 90% of malaria cases in humans. Stephanie Tam reports on a new online training programme ...

The outlook for the US economy remains weak despite a temporary cooling of the US-China trade war, a Reuters poll of ...